newsfilter
← Latest News
GlobeNewswire·

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

  • Tenaya Therapeutics (NASDAQ: TNYA) will host investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026.
  • The company will also present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026.
  • A fireside chat from the H.C. Wainwright conference will be available on demand starting Friday, September 11, 2026, at 7:00 AM ET.
  • The conference recording will be archived on Tenaya's investor website for approximately 30 days.
  • Tenaya's pipeline includes TN-201, a gene therapy for MYBPC3-associated hypertrophic cardiomyopathy.
  • The portfolio features TN-401, a gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy.
  • TN-301 is a small molecule HDAC6 inhibitor with potential applications in heart failure with preserved ejection fraction and Duchenne muscular dystrophy.
  • Tenaya utilizes modality agnostic target discovery to develop novel medicines for rare genetic disorders and prevalent heart conditions.